Stockreport

C4 Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 [Yahoo! Finance]

C4 Therapeutics, Inc.  (CCCC) 
NASDAQ:AMEX Investor Relations: ir.chinacache.com
PDF to advancing targeted protein degradation (TPD) science, today announced that C4T management will participate in a fireside chat at the Guggenheim Emerging Outlook: Biot [Read more]